7Baggers
Quarterly
Annual
    Unit: USD2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2020-12-31 2019-06-30 2019-03-31 2018-12-31 
      
    		           
      operating activities:
    		           
      consolidated net income
    		16,400,000 -22,700,000 110,700,000 203,100,000 -2,004,800,000 46,800,000 344,900,000 152,500,000 253,800,000 161,900,000 139,800,000 
      adjustments to reconcile consolidated net income to net cash from operating activities:
    		           
      depreciation, depletion and amortization
    		388,400,000 381,800,000 384,300,000 382,500,000 395,800,000 373,200,000 371,200,000 364,500,000 385,300,000 383,700,000 359,100,000 
      deferred income tax benefit
    		-10,000,000 -23,300,000 -125,900,000 -109,700,000 -220,100,000 -19,500,000      
      share-based compensation expense
    		5,700,000 7,300,000 8,600,000 32,500,000 13,500,000 9,600,000 19,000,000 20,000,000 15,800,000 18,100,000 17,400,000 
      pension and other postretirement cost, net of contributions
    		           
      cash surrender value increase in excess of premiums paid
    		-14,500,000 -17,400,000 -400,000 -12,400,000 -12,300,000 -13,100,000 500,000     
      equity in (income) loss of unconsolidated entities
    		-2,900,000 -4,200,000          
      loss on sale of rts and chattanooga
    		           
      gain on sale of businesses
    		   -100,000 0 -11,100,000      
      impairment of goodwill
    		           
      other impairment adjustments
    		4,700,000 -4,800,000 229,800,000 19,600,000 388,400,000 -700,000 11,200,000  500,000 7,200,000 2,800,000 
      gain on disposal of assets
    		 -2,300,000          
      other
    		700,000 -2,000,000 -5,300,000 -14,800,000 -15,000,000 700,000 63,900,000 -31,500,000 -15,200,000 -28,000,000 -18,300,000 
      change in operating assets and liabilities, net of acquisitions and divestitures:
    		           
      accounts receivable
    		-154,700,000 181,500,000 131,000,000 105,800,000 -114,600,000 284,900,000 98,500,000 150,200,000 -23,400,000 -52,400,000 169,700,000 
      inventories
    		-30,000,000 -25,700,000 137,200,000 15,400,000 9,000,000 -53,800,000 -46,500,000 -44,300,000 28,000,000 3,900,000 -71,400,000 
      other assets
    		-7,200,000 -73,500,000 -144,300,000 -69,900,000 14,600,000 -64,300,000 257,500,000 -19,300,000 -42,800,000 -111,100,000 -17,800,000 
      accounts payable
    		8,900,000 -23,500,000 -40,600,000 -25,400,000 -100,400,000 -113,900,000 -40,500,000 -5,400,000 17,100,000 5,100,000 -148,500,000 
      income taxes
    		-186,500,000 10,800,000 -21,300,000 65,600,000 46,500,000 200,000 -112,500,000 50,600,000 -2,500,000 -15,500,000 -11,500,000 
      accrued liabilities and other
    		12,700,000 -107,000,000 162,000,000 118,900,000 -1,700,000 -211,000,000 -331,200,000 116,900,000 127,600,000 -32,800,000 -87,500,000 
      net cash from operating activities
    		37,100,000 275,000,000 584,300,000 693,600,000 284,100,000 265,900,000 540,300,000 719,400,000 734,600,000 361,900,000 303,100,000 
      investing activities:
    		           
      capital expenditures
    		-301,300,000 -247,300,000 -323,800,000 -254,600,000 -281,500,000 -282,200,000 -293,100,000 -170,700,000 -351,400,000 -303,400,000 -322,000,000 
      free cash flows
    		-264,200,000 27,700,000 260,500,000 439,000,000 2,600,000 -16,300,000 247,200,000 548,700,000 383,200,000 58,500,000 -18,900,000 
      cash paid for purchase of businesses, net of cash received
    		   0 0 -853,500,000      
      proceeds from settlement of timber note related to spes
    		0 860,000,000          
      proceeds from corporate owned life insurance
    		1,900,000 3,100,000 6,200,000 29,300,000 4,500,000 2,200,000 31,000,000     
      proceeds from sale of businesses
    		300,000 500,000  400,000 0 25,900,000      
      proceeds from currency forward contracts
    		  0 0 0 23,200,000      
      proceeds from the sale of unconsolidated entities
    		0 1,000,000          
      proceeds from sale of property, plant and equipment
    		30,400,000 8,300,000 5,100,000 3,000,000 14,200,000 4,500,000 2,600,000 2,000,000 3,000,000 17,300,000 88,000,000 
      net cash from investing activities
    		-268,700,000 625,400,000 14,800,000 -178,500,000 -263,300,000 -1,080,200,000 -261,800,000 -140,400,000 -350,100,000 -277,800,000 -3,572,800,000 
      financing activities:
    		           
      additions to revolving credit facilities
    		  0 10,600,000 32,100,000 10,200,000  180,000,000 -124,300,000 38,400,000 133,600,000 
      repayments of revolving credit facilities
    		  -32,700,000 -195,200,000 0 -116,300,000 -273,300,000 -10,000,000    
      additions to debt
    		2,200,000 102,300,000 76,200,000 381,100,000 -10,700,000 1,389,800,000 6,900,000 10,800,000 483,100,000 151,800,000 3,806,100,000 
      repayments of debt
    		-35,200,000 -35,000,000 -595,200,000 -608,900,000 -6,000,000 -510,700,000 -210,000,000 -704,500,000 -1,455,400,000 -361,700,000 -2,847,900,000 
      changes in commercial paper
    		314,900,000 -34,700,000 134,300,000 -141,800,000 -10,100,000 301,500,000   -142,700,000 140,600,000 447,700,000 
      other debt repayments
    		           
      repayment of timber loan related to spes
    		0 -774,000,000          
      cash dividends paid to stockholders
    		-78,000,000 -77,600,000 -70,500,000 -70,500,000 -70,300,000 -70,000,000 -63,600,000 -52,600,000 -117,000,000 -117,600,000 -116,100,000 
      net cash from financing activities
    		234,300,000 -804,000,000 -529,700,000 -571,400,000 -75,300,000 982,900,000 -315,500,000 -584,100,000 -365,300,000 -191,800,000 2,896,600,000 
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		3,900,000 -1,700,000 -2,300,000 10,300,000 3,700,000 -5,700,000 -8,200,000 7,800,000 5,700,000 1,200,000 -3,000,000 
      changes in cash, cash equivalents and restricted cash in assets held-for-sale
    		   -2,600,000 -1,000,000 -7,900,000      
      increase in cash, cash equivalents and restricted cash
    		6,600,000 94,700,000 78,600,000 -48,600,000 -51,800,000 155,000,000 -45,200,000 2,700,000   -376,100,000 
      cash, cash equivalents and restricted cash at beginning of period
    		0 393,400,000 0 0 0 260,200,000 0 251,100,000 0 0 636,800,000 
      cash, cash equivalents and restricted cash at end of period
    		6,600,000 488,100,000 78,600,000 -48,600,000 -51,800,000 415,200,000 -45,200,000 253,800,000 24,900,000 -106,500,000 260,700,000 
      pension and other postretirement cost (income), net of contributions
    		 500,000          
      gain on sale of rts and chattanooga
    		 -500,000          
      other debt additions (repayments)
    		 16,500,000      21,600,000    
      401(k) match and company contribution in common stock
    		      0     
      pension and other postretirement funding
    		        -17,300,000 -14,200,000 -12,800,000 
      equity in income of unconsolidated entities
    		           
      gain on sale of other businesses
    		           
      gain on sale of investment
    		       -14,700,000    
      impairment of goodwill and mineral rights
    		           
      (gain) loss on disposal of plant, equipment and other
    		           
      cash paid for purchase of businesses, net of cash acquired
    		           
      proceeds from sale of rts and chattanooga
    		           
      proceeds from sale of other businesses
    		           
      proceeds from sale of investment
    		       23,300,000    
      proceeds from property, plant and equipment insurance settlement
    		      0  7,700,000   
      other debt (repayments) additions
    		    7,500,000 -23,600,000      
      purchases of common stock
    		      0  0 -44,400,000 -44,200,000 
      pension and other postretirement funding more than cost
    		   5,200,000 4,600,000 3,600,000      
      equity in loss (income) of unconsolidated entities
    		   -23,700,000 -4,500,000 36,000,000      
      impairment of goodwill and other assets
    		           
      gain on disposal of plant and equipment and other
    		   1,000,000 -7,900,000 -1,700,000  2,600,000  -2,300,000 -43,200,000 
      proceeds from the sale of unconsolidated entity
    		           
      other debt additions
    		           
      issuances of common stock, net of related tax withholdings
    		   2,300,000 -18,700,000 2,400,000 3,300,000     
      goodwill impairment
    		           
      cost of real estate sold
    		        6,300,000 0 11,000,000 
      deferred income tax (benefit) expense
    		       -19,600,000    
      pension and other postretirement funding more than expense
    		      -33,800,000 -28,000,000    
      gain on sale of sawmill
    		           
      mineral rights impairment
    		      0     
      proceeds from sale of sawmill
    		           
      proceeds from issuance of notes
    		        999,700,000 0 1,498,500,000 
      (gain) loss on disposal of plant and equipment and other
    		           
      land and development impairments
    		        0   
      gain on disposal of plant, equipment and other
    		           
      other financing additions
    		           
      401(k) match in common stock
    		       24,900,000    
      investment in unconsolidated entities
    		       -100,000 -10,200,000   
      additions to commercial paper
    		           
      issuances of common stock, net of related minimum tax withholdings
    		       -12,400,000 5,400,000 -9,700,000 12,900,000 
      cash distributions paid to noncontrolling interests
    		       -400,000 -600,000 -600,000 -2,200,000 
      deferred income tax expense
    		        -3,200,000 25,300,000 14,300,000 
      multiemployer pension withdrawal expense
    		           
      cash paid related to business combinations, net of cash acquired
    		        -19,000,000   
      (repayments) additions to commercial paper
    		           
      multiemployer pension withdrawals
    		           
      cash receipts on sold trade receivables
    		           
      other financing additions (repayments)
    		        -3,400,000 2,000,000 14,600,000 
      decrease in cash, cash equivalents and restricted cash
    		           
      cash (paid) received related to business combinations, net of cash acquired
    		          -3,342,900,000 
      gain on sale of hh&b
    		           
      impairment of specialty chemicals goodwill and intangibles
    		           
      debt purchased in connection with an acquisition
    		           
      proceeds from sale of hh&b
    		           
      (repayments) additions to revolving credit facilities
    		           
      other financing (repayments) additions
    		           
      specialty chemicals spin-off of net cash and trust funding
    		           
      effect of exchange rate changes on cash and cash equivalents
    		           
      increase in cash and cash equivalents
    		           
      cash and cash equivalents at beginning of period
    		           
      cash and cash equivalents at end of period
    		           
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.